<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/bjc/journal/vaop/ncurrent/rss.rdf">
<title>British Journal of Cancer - AOP - nature.com science feeds</title>
<description>The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.</description>
<link>http://www.nature.com/bjc/journal/vaop/ncurrent/rss.rdf</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights> Copyright
                    ©  Cancer Research UK</dc:rights>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:issn>0007-0920</prism:issn>
<prism:copyright> Copyright
                    ©  Cancer Research UK</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/bjc.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605464" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605506" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605515" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605517" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605520" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605526" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605527" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605528" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605530" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605532" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605535" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605536" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605537" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605540" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605541" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605542" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605543" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605544" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605545" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605546" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605548" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605549" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605550" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605551" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605552" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605553" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605554" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605556" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605558" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605559" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605561" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605562" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605563" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605564" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605567" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.bjc.6605572" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rdf+xml" href="http://feeds.nature.com/bjc/rss/aop" /><feedburner:info uri="bjc/rss/aop" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/bjc.gif">
<title>British Journal of Cancer</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/bjc.gif</url>
<link>http://www.nature.com/bjc/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605464">
<title>Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/V62cv1Tyv8A/sj.bjc.6605464</link>
<content:encoded><![CDATA[
            
<p>
<b>Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605464">doi:10.1038/sj.bjc.6605464</a>
</p>
<p>Authors: S A Rebuffat, M Morin, B Nguyen, F Castex, B Robert
                    &amp; S P&#233;raldi-Roux</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/V62cv1Tyv8A" height="1" width="1"/>]]></content:encoded>
<dc:title>Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO</dc:title>
<dc:creator>S A Rebuffat</dc:creator>
<dc:creator>M Morin</dc:creator>
<dc:creator>B Nguyen</dc:creator>
<dc:creator>F Castex</dc:creator>
<dc:creator>B Robert</dc:creator>
<dc:creator>S Péraldi-Roux</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605464</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605464</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605464</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605464</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605506">
<title>In vivo effects of rosiglitazone in a human neuroblastoma xenograft</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/UJEwMZzEiAE/sj.bjc.6605506</link>
<content:encoded><![CDATA[
            
<p>
<b>In vivo effects of rosiglitazone in a human neuroblastoma xenograft</b>
</p>
<p>British Journal of Cancer advance online publication, January 12, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605506">doi:10.1038/sj.bjc.6605506</a>
</p>
<p>Authors: I Cellai, G Petrangolini, M Tortoreto, G Pratesi, P Luciani, C Deledda, S Benvenuti, C Ricordati, S Gelmini, E Ceni, A Galli, M Balzi, P Faraoni, M Serio
                    &amp; A Peri</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/UJEwMZzEiAE" height="1" width="1"/>]]></content:encoded>
<dc:title>In vivo effects of rosiglitazone in a human neuroblastoma xenograft</dc:title>
<dc:creator>I Cellai</dc:creator>
<dc:creator>G Petrangolini</dc:creator>
<dc:creator>M Tortoreto</dc:creator>
<dc:creator>G Pratesi</dc:creator>
<dc:creator>P Luciani</dc:creator>
<dc:creator>C Deledda</dc:creator>
<dc:creator>S Benvenuti</dc:creator>
<dc:creator>C Ricordati</dc:creator>
<dc:creator>S Gelmini</dc:creator>
<dc:creator>E Ceni</dc:creator>
<dc:creator>A Galli</dc:creator>
<dc:creator>M Balzi</dc:creator>
<dc:creator>P Faraoni</dc:creator>
<dc:creator>M Serio</dc:creator>
<dc:creator>A Peri</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605506</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 12, 2010</dc:source>
<dc:date>2010-01-12</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 12, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605506</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605506</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605506</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605515">
<title>Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/E2lyPYt96bc/sj.bjc.6605515</link>
<content:encoded><![CDATA[
            
<p>
<b>Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605515">doi:10.1038/sj.bjc.6605515</a>
</p>
<p>Authors: O Galamb, S Spis&#225;k, F Sipos, K T&#243;th, N Solymosi, B Wichmann, T Kren&#225;cs, G Valcz, Z Tulassay
                    &amp; B Moln&#225;r</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/E2lyPYt96bc" height="1" width="1"/>]]></content:encoded>
<dc:title>Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor</dc:title>
<dc:creator>O Galamb</dc:creator>
<dc:creator>S Spisák</dc:creator>
<dc:creator>F Sipos</dc:creator>
<dc:creator>K Tóth</dc:creator>
<dc:creator>N Solymosi</dc:creator>
<dc:creator>B Wichmann</dc:creator>
<dc:creator>T Krenács</dc:creator>
<dc:creator>G Valcz</dc:creator>
<dc:creator>Z Tulassay</dc:creator>
<dc:creator>B Molnár</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605515</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605515</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605515</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605515</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605517">
<title>Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/qy0nSG63-h0/sj.bjc.6605517</link>
<content:encoded><![CDATA[
            
<p>
<b>Oestrogen receptor-&#945; contributes to the regulation of the hedgehog signalling pathway in ER&#945;-positive gastric cancer</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605517">doi:10.1038/sj.bjc.6605517</a>
</p>
<p>Authors: C Kameda, M Nakamura, H Tanaka, A Yamasaki, M Kubo, M Tanaka, H Onishi
                    &amp; M Katano</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/qy0nSG63-h0" height="1" width="1"/>]]></content:encoded>
<dc:title>Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer</dc:title>
<dc:creator>C Kameda</dc:creator>
<dc:creator>M Nakamura</dc:creator>
<dc:creator>H Tanaka</dc:creator>
<dc:creator>A Yamasaki</dc:creator>
<dc:creator>M Kubo</dc:creator>
<dc:creator>M Tanaka</dc:creator>
<dc:creator>H Onishi</dc:creator>
<dc:creator>M Katano</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605517</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605517</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605517</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605517</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605520">
<title>Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/DOB_7wv55Wk/sj.bjc.6605520</link>
<content:encoded><![CDATA[
            
<p>
<b>Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients</b>
</p>
<p>British Journal of Cancer advance online publication, January 5, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605520">doi:10.1038/sj.bjc.6605520</a>
</p>
<p>Authors: H Taubert, P W&#252;rl, T Greither, M Kappler, M Bache, C Lautenschl&#228;ger, S F&#252;ssel, A Meye, A W Eckert, H-J Holzhausen, V Magdolen
                    &amp; M Kotzsch</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/DOB_7wv55Wk" height="1" width="1"/>]]></content:encoded>
<dc:title>Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients</dc:title>
<dc:creator>H Taubert</dc:creator>
<dc:creator>P Würl</dc:creator>
<dc:creator>T Greither</dc:creator>
<dc:creator>M Kappler</dc:creator>
<dc:creator>M Bache</dc:creator>
<dc:creator>C Lautenschläger</dc:creator>
<dc:creator>S Füssel</dc:creator>
<dc:creator>A Meye</dc:creator>
<dc:creator>A W Eckert</dc:creator>
<dc:creator>H-J Holzhausen</dc:creator>
<dc:creator>V Magdolen</dc:creator>
<dc:creator>M Kotzsch</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605520</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 5, 2010</dc:source>
<dc:date>2010-01-05</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 5, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605520</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605520</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605520</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605526">
<title>Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/cKPr2vHgHhI/sj.bjc.6605526</link>
<content:encoded><![CDATA[
            
<p>
<b>Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605526">doi:10.1038/sj.bjc.6605526</a>
</p>
<p>Authors: S Behboudi, A Alisa, S Boswell, J Anastassiou, A A Pathan
                    &amp; R Williams</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/cKPr2vHgHhI" height="1" width="1"/>]]></content:encoded>
<dc:title>Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease</dc:title>
<dc:creator>S Behboudi</dc:creator>
<dc:creator>A Alisa</dc:creator>
<dc:creator>S Boswell</dc:creator>
<dc:creator>J Anastassiou</dc:creator>
<dc:creator>A A Pathan</dc:creator>
<dc:creator>R Williams</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605526</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605526</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605526</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605526</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605527">
<title>Treatment options for small cell lung cancer – do we have more choice?</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/AMSs7cZTyqI/sj.bjc.6605527</link>
<content:encoded><![CDATA[
            
<p>
<b>Treatment options for small cell lung cancer &#8211; do we have more choice&#63;</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605527">doi:10.1038/sj.bjc.6605527</a>
</p>
<p>Authors: M Puglisi, S Dolly, A Faria, J S Myerson, S Popat
                    &amp; M E R O'Brien</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/AMSs7cZTyqI" height="1" width="1"/>]]></content:encoded>
<dc:title>Treatment options for small cell lung cancer – do we have more choice?</dc:title>
<dc:creator>M Puglisi</dc:creator>
<dc:creator>S Dolly</dc:creator>
<dc:creator>A Faria</dc:creator>
<dc:creator>J S Myerson</dc:creator>
<dc:creator>S Popat</dc:creator>
<dc:creator>M E R O'Brien</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605527</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605527</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605527</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605527</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605528">
<title>Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/HsqHdjyDaNQ/sj.bjc.6605528</link>
<content:encoded><![CDATA[
            
<p>
<b>Predicted impact of vaccination against human papillomavirus 16&#47;18 on cancer incidence and cervical abnormalities in women aged 20&#8211;29 in the UK</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605528">doi:10.1038/sj.bjc.6605528</a>
</p>
<p>Authors: J Cuzick, A Casta&#241;&#243;n
                    &amp; P Sasieni</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/HsqHdjyDaNQ" height="1" width="1"/>]]></content:encoded>
<dc:title>Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK</dc:title>
<dc:creator>J Cuzick</dc:creator>
<dc:creator>A Castañón</dc:creator>
<dc:creator>P Sasieni</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605528</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605528</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605528</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605528</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605530">
<title>TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/ruHMbtQ8D30/sj.bjc.6605530</link>
<content:encoded><![CDATA[
            
<p>
<b>TNF-&#945;&#47;NF-&#954;B&#47;Snail pathway in cancer cell migration and invasion</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605530">doi:10.1038/sj.bjc.6605530</a>
</p>
<p>Authors: Y Wu
                    &amp; B P Zhou</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/ruHMbtQ8D30" height="1" width="1"/>]]></content:encoded>
<dc:title>TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion</dc:title>
<dc:creator>Y Wu</dc:creator>
<dc:creator>B P Zhou</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605530</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605530</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605530</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605530</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605532">
<title>Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/GYqkcIvQI1E/sj.bjc.6605532</link>
<content:encoded><![CDATA[
            
<p>
<b>Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605532">doi:10.1038/sj.bjc.6605532</a>
</p>
<p>Authors: R J E Skipworth, D A C Deans, B H L Tan, K Sangster, S Paterson-Brown, D A Brown, M Hunter, S N Breit, J A Ross
                    &amp; K C H Fearon</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/GYqkcIvQI1E" height="1" width="1"/>]]></content:encoded>
<dc:title>Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer</dc:title>
<dc:creator>R J E Skipworth</dc:creator>
<dc:creator>D A C Deans</dc:creator>
<dc:creator>B H L Tan</dc:creator>
<dc:creator>K Sangster</dc:creator>
<dc:creator>S Paterson-Brown</dc:creator>
<dc:creator>D A Brown</dc:creator>
<dc:creator>M Hunter</dc:creator>
<dc:creator>S N Breit</dc:creator>
<dc:creator>J A Ross</dc:creator>
<dc:creator>K C H Fearon</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605532</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605532</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605532</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605532</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605535">
<title>The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/ioo3_0CTUgk/sj.bjc.6605535</link>
<content:encoded><![CDATA[
            
<p>
<b>The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model</b>
</p>
<p>British Journal of Cancer advance online publication, February 2, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605535">doi:10.1038/sj.bjc.6605535</a>
</p>
<p>Authors: I Debergh, N Van Damme, P Pattyn, M Peeters
                    &amp; W P Ceelen</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/ioo3_0CTUgk" height="1" width="1"/>]]></content:encoded>
<dc:title>The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model</dc:title>
<dc:creator>I Debergh</dc:creator>
<dc:creator>N Van Damme</dc:creator>
<dc:creator>P Pattyn</dc:creator>
<dc:creator>M Peeters</dc:creator>
<dc:creator>W P Ceelen</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605535</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 2, 2010</dc:source>
<dc:date> 201-02-02</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 2, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605535</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605535</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605535</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605536">
<title>Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/vsea3mCaoO4/sj.bjc.6605536</link>
<content:encoded><![CDATA[
            
<p>
<b>Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605536">doi:10.1038/sj.bjc.6605536</a>
</p>
<p>Authors: T Ishiguro, H Avila, S-Y Lin, T Nakamura, M Yamamoto
                    &amp; D D Boyd</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/vsea3mCaoO4" height="1" width="1"/>]]></content:encoded>
<dc:title>Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases</dc:title>
<dc:creator>T Ishiguro</dc:creator>
<dc:creator>H Avila</dc:creator>
<dc:creator>S-Y Lin</dc:creator>
<dc:creator>T Nakamura</dc:creator>
<dc:creator>M Yamamoto</dc:creator>
<dc:creator>D D Boyd</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605536</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605536</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605536</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605536</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605537">
<title>Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/7x8d0fexzEs/sj.bjc.6605537</link>
<content:encoded><![CDATA[
            
<p>
<b>Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605537">doi:10.1038/sj.bjc.6605537</a>
</p>
<p>Authors: T-Y Jeon, M-E Han, Y-W Lee, Y-S Lee, G-H Kim, G-A Song, G-Y Hur, J-Y Kim, H-J Kim, S Yoon, S-Y Baek, B-S Kim, J-B Kim
                    &amp; S-O Oh</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/7x8d0fexzEs" height="1" width="1"/>]]></content:encoded>
<dc:title>Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells</dc:title>
<dc:creator>T-Y Jeon</dc:creator>
<dc:creator>M-E Han</dc:creator>
<dc:creator>Y-W Lee</dc:creator>
<dc:creator>Y-S Lee</dc:creator>
<dc:creator>G-H Kim</dc:creator>
<dc:creator>G-A Song</dc:creator>
<dc:creator>G-Y Hur</dc:creator>
<dc:creator>J-Y Kim</dc:creator>
<dc:creator>H-J Kim</dc:creator>
<dc:creator>S Yoon</dc:creator>
<dc:creator>S-Y Baek</dc:creator>
<dc:creator>B-S Kim</dc:creator>
<dc:creator>J-B Kim</dc:creator>
<dc:creator>S-O Oh</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605537</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605537</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605537</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605537</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605540">
<title>p53 mutation, deprivation and poor prognosis in primary breast cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/sMvj8ge_G04/sj.bjc.6605540</link>
<content:encoded><![CDATA[
            
<p>
<b>p53 mutation, deprivation and poor prognosis in primary breast cancer</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605540">doi:10.1038/sj.bjc.6605540</a>
</p>
<p>Authors: L Baker, P R Quinlan, N Patten, A Ashfield, L-J Birse-Stewart-Bell, C McCowan, J-C Bourdon, C A Purdie, L B Jordan, J A Dewar, L Wu
                    &amp; A M Thompson</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/sMvj8ge_G04" height="1" width="1"/>]]></content:encoded>
<dc:title>p53 mutation, deprivation and poor prognosis in primary breast cancer</dc:title>
<dc:creator>L Baker</dc:creator>
<dc:creator>P R Quinlan</dc:creator>
<dc:creator>N Patten</dc:creator>
<dc:creator>A Ashfield</dc:creator>
<dc:creator>L-J Birse-Stewart-Bell</dc:creator>
<dc:creator>C McCowan</dc:creator>
<dc:creator>J-C Bourdon</dc:creator>
<dc:creator>C A Purdie</dc:creator>
<dc:creator>L B Jordan</dc:creator>
<dc:creator>J A Dewar</dc:creator>
<dc:creator>L Wu</dc:creator>
<dc:creator>A M Thompson</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605540</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605540</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605540</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605540</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605541">
<title>Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/8INg5wZdx5Y/sj.bjc.6605541</link>
<content:encoded><![CDATA[
            
<p>
<b>Human apurinic&#47;apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605541">doi:10.1038/sj.bjc.6605541</a>
</p>
<p>Authors: A Al-Attar, L Gossage, K R Fareed, M Shehata, M Mohammed, A M Zaitoun, I Soomro, D N Lobo, R Abbotts, S Chan
                    &amp; S Madhusudan</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/8INg5wZdx5Y" height="1" width="1"/>]]></content:encoded>
<dc:title>Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers</dc:title>
<dc:creator>A Al-Attar</dc:creator>
<dc:creator>L Gossage</dc:creator>
<dc:creator>K R Fareed</dc:creator>
<dc:creator>M Shehata</dc:creator>
<dc:creator>M Mohammed</dc:creator>
<dc:creator>A M Zaitoun</dc:creator>
<dc:creator>I Soomro</dc:creator>
<dc:creator>D N Lobo</dc:creator>
<dc:creator>R Abbotts</dc:creator>
<dc:creator>S Chan</dc:creator>
<dc:creator>S Madhusudan</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605541</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605541</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605541</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605541</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605542">
<title>IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/CyN-wV6nHKE/sj.bjc.6605542</link>
<content:encoded><![CDATA[
            
<p>
<b>IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605542">doi:10.1038/sj.bjc.6605542</a>
</p>
<p>Authors: G N Malavige, L T Rohanachandra, L Jones, L Crack, M Perera, N Fernando, D Guruge
                    &amp; G S Ogg</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/CyN-wV6nHKE" height="1" width="1"/>]]></content:encoded>
<dc:title>IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies</dc:title>
<dc:creator>G N Malavige</dc:creator>
<dc:creator>L T Rohanachandra</dc:creator>
<dc:creator>L Jones</dc:creator>
<dc:creator>L Crack</dc:creator>
<dc:creator>M Perera</dc:creator>
<dc:creator>N Fernando</dc:creator>
<dc:creator>D Guruge</dc:creator>
<dc:creator>G S Ogg</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605542</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605542</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605542</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605542</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605543">
<title>Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/k0fJqU-mWCo/sj.bjc.6605543</link>
<content:encoded><![CDATA[
            
<p>
<b>Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12&#47;Hypo, derived from a scirrhous gastric carcinoma</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605543">doi:10.1038/sj.bjc.6605543</a>
</p>
<p>Authors: Y Kato, M Yashiro, S Noda, M Tendo, S Kashiwagi, Y Doi, T Nishii, J Matsuoka, Y Fuyuhiro, O Shinto, T Sawada, M Ohira
                    &amp; K Hirakawa</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/k0fJqU-mWCo" height="1" width="1"/>]]></content:encoded>
<dc:title>Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma</dc:title>
<dc:creator>Y Kato</dc:creator>
<dc:creator>M Yashiro</dc:creator>
<dc:creator>S Noda</dc:creator>
<dc:creator>M Tendo</dc:creator>
<dc:creator>S Kashiwagi</dc:creator>
<dc:creator>Y Doi</dc:creator>
<dc:creator>T Nishii</dc:creator>
<dc:creator>J Matsuoka</dc:creator>
<dc:creator>Y Fuyuhiro</dc:creator>
<dc:creator>O Shinto</dc:creator>
<dc:creator>T Sawada</dc:creator>
<dc:creator>M Ohira</dc:creator>
<dc:creator>K Hirakawa</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605543</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605543</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605543</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605543</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605544">
<title>Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/lWx8kOKMGxA/sj.bjc.6605544</link>
<content:encoded><![CDATA[
            
<p>
<b>Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605544">doi:10.1038/sj.bjc.6605544</a>
</p>
<p>Authors: V H&#228;yry, L K M&#228;kinen, T Atula, H Sariola, A M&#228;kitie, I Leivo, H Keski-S&#228;ntti, J Lundin, C Haglund
                    &amp; J Hagstr&#246;m</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/lWx8kOKMGxA" height="1" width="1"/>]]></content:encoded>
<dc:title>Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue</dc:title>
<dc:creator>V Häyry</dc:creator>
<dc:creator>L K Mäkinen</dc:creator>
<dc:creator>T Atula</dc:creator>
<dc:creator>H Sariola</dc:creator>
<dc:creator>A Mäkitie</dc:creator>
<dc:creator>I Leivo</dc:creator>
<dc:creator>H Keski-Säntti</dc:creator>
<dc:creator>J Lundin</dc:creator>
<dc:creator>C Haglund</dc:creator>
<dc:creator>J Hagström</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605544</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605544</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605544</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605544</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605545">
<title>Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/Gz-R-b6RJJM/sj.bjc.6605545</link>
<content:encoded><![CDATA[
            
<p>
<b>Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605545">doi:10.1038/sj.bjc.6605545</a>
</p>
<p>Authors: D Mahalingam, A Natoni, M Keane, A Samali
                    &amp; E Szegezdi</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/Gz-R-b6RJJM" height="1" width="1"/>]]></content:encoded>
<dc:title>Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells</dc:title>
<dc:creator>D Mahalingam</dc:creator>
<dc:creator>A Natoni</dc:creator>
<dc:creator>M Keane</dc:creator>
<dc:creator>A Samali</dc:creator>
<dc:creator>E Szegezdi</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605545</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605545</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605545</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605545</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605546">
<title>Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/q-kcRoknayU/sj.bjc.6605546</link>
<content:encoded><![CDATA[
            
<p>
<b>Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605546">doi:10.1038/sj.bjc.6605546</a>
</p>
<p>Authors: T Hamaoka, C M Costelloe, J E Madewell, P Liu, D A Berry, R Islam, R L Theriault, G N Hortobagyi
                    &amp; N T Ueno</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/q-kcRoknayU" height="1" width="1"/>]]></content:encoded>
<dc:title>Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer</dc:title>
<dc:creator>T Hamaoka</dc:creator>
<dc:creator>C M Costelloe</dc:creator>
<dc:creator>J E Madewell</dc:creator>
<dc:creator>P Liu</dc:creator>
<dc:creator>D A Berry</dc:creator>
<dc:creator>R Islam</dc:creator>
<dc:creator>R L Theriault</dc:creator>
<dc:creator>G N Hortobagyi</dc:creator>
<dc:creator>N T Ueno</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605546</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605546</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605546</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605546</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605548">
<title>Assessment of fracture risk in women with breast cancer using current vs emerging guidelines</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/y91qZyuZkPE/sj.bjc.6605548</link>
<content:encoded><![CDATA[
            
<p>
<b>Assessment of fracture risk in women with breast cancer using current vs emerging guidelines</b>
</p>
<p>British Journal of Cancer advance online publication, January 19, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605548">doi:10.1038/sj.bjc.6605548</a>
</p>
<p>Authors: P Hadji, M Ziller, U S Albert
                    &amp; M Kalder</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/y91qZyuZkPE" height="1" width="1"/>]]></content:encoded>
<dc:title>Assessment of fracture risk in women with breast cancer using current vs emerging guidelines</dc:title>
<dc:creator>P Hadji</dc:creator>
<dc:creator>M Ziller</dc:creator>
<dc:creator>U S Albert</dc:creator>
<dc:creator>M Kalder</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605548</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 19, 2010</dc:source>
<dc:date>2010-01-19</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 19, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605548</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605548</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605548</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605549">
<title>Regarding: Koilocytes indicate a role for human papilloma virus in breast cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/sxQdtwz7x3s/sj.bjc.6605549</link>
<content:encoded><![CDATA[
            
<p>
<b>Regarding: Koilocytes indicate a role for human papilloma virus in breast cancer</b>
</p>
<p>British Journal of Cancer advance online publication, February 2, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605549">doi:10.1038/sj.bjc.6605549</a>
</p>
<p>Author: R E Sandstrom</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/sxQdtwz7x3s" height="1" width="1"/>]]></content:encoded>
<dc:title>Regarding: Koilocytes indicate a role for human papilloma virus in breast cancer</dc:title>
<dc:creator>R E Sandstrom</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605549</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 2, 2010</dc:source>
<dc:date> 201-02-02</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 2, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605549</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605549</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605549</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605550">
<title>Reply: Koilocytes indicate a role for human papilloma virus in breast</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/tXfFjb4IY0g/sj.bjc.6605550</link>
<content:encoded><![CDATA[
            
<p>
<b>Reply: Koilocytes indicate a role for human papilloma virus in breast</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605550">doi:10.1038/sj.bjc.6605550</a>
</p>
<p>Authors: W K Glenn, B Heng, N J Whitaker
                    &amp; J S Lawson</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/tXfFjb4IY0g" height="1" width="1"/>]]></content:encoded>
<dc:title>Reply: Koilocytes indicate a role for human papilloma virus in breast</dc:title>
<dc:creator>W K Glenn</dc:creator>
<dc:creator>B Heng</dc:creator>
<dc:creator>N J Whitaker</dc:creator>
<dc:creator>J S Lawson</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605550</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605550</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605550</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605550</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605551">
<title>Hypoxia inducible factors in cancer stem cells</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/OJ9BE2l3YUA/sj.bjc.6605551</link>
<content:encoded><![CDATA[
            
<p>
<b>Hypoxia inducible factors in cancer stem cells</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605551">doi:10.1038/sj.bjc.6605551</a>
</p>
<p>Authors: J M Heddleston, Z Li, J D Lathia, S Bao, A B Hjelmeland
                    &amp; J N Rich</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/OJ9BE2l3YUA" height="1" width="1"/>]]></content:encoded>
<dc:title>Hypoxia inducible factors in cancer stem cells</dc:title>
<dc:creator>J M Heddleston</dc:creator>
<dc:creator>Z Li</dc:creator>
<dc:creator>J D Lathia</dc:creator>
<dc:creator>S Bao</dc:creator>
<dc:creator>A B Hjelmeland</dc:creator>
<dc:creator>J N Rich</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605551</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605551</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605551</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605551</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605552">
<title>Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/SQxVMCU-28c/sj.bjc.6605552</link>
<content:encoded><![CDATA[
            
<p>
<b>Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-&#945; in a phase III trial: final results and geographical analysis</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605552">doi:10.1038/sj.bjc.6605552</a>
</p>
<p>Authors: D Cella, M D Michaelson, A G Bushmakin, J C Cappelleri, C Charbonneau, S T Kim, J Z Li
                    &amp; R J Motzer</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/SQxVMCU-28c" height="1" width="1"/>]]></content:encoded>
<dc:title>Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis</dc:title>
<dc:creator>D Cella</dc:creator>
<dc:creator>M D Michaelson</dc:creator>
<dc:creator>A G Bushmakin</dc:creator>
<dc:creator>J C Cappelleri</dc:creator>
<dc:creator>C Charbonneau</dc:creator>
<dc:creator>S T Kim</dc:creator>
<dc:creator>J Z Li</dc:creator>
<dc:creator>R J Motzer</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605552</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605552</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605552</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605552</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605553">
<title>Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/r4B6Ni4AglE/sj.bjc.6605553</link>
<content:encoded><![CDATA[
            
<p>
<b>Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605553">doi:10.1038/sj.bjc.6605553</a>
</p>
<p>Authors: T Nakanishi, S Chumsri, N Khakpour, A H Brodie, B Leyland-Jones, A W Hamburger, D D Ross
                    &amp; A M Burger</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/r4B6Ni4AglE" height="1" width="1"/>]]></content:encoded>
<dc:title>Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling</dc:title>
<dc:creator>T Nakanishi</dc:creator>
<dc:creator>S Chumsri</dc:creator>
<dc:creator>N Khakpour</dc:creator>
<dc:creator>A H Brodie</dc:creator>
<dc:creator>B Leyland-Jones</dc:creator>
<dc:creator>A W Hamburger</dc:creator>
<dc:creator>D D Ross</dc:creator>
<dc:creator>A M Burger</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605553</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605553</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605553</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605553</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605554">
<title>Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/xqIYYfhUFdY/sj.bjc.6605554</link>
<content:encoded><![CDATA[
            
<p>
<b>Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer</b>
</p>
<p>British Journal of Cancer advance online publication, January 26, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605554">doi:10.1038/sj.bjc.6605554</a>
</p>
<p>Authors: A H M Reid, G Attard, L Ambroisine, G Fisher, G Kovacs, D Brewer, J Clark, P Flohr, S Edwards, D M Berney, C S Foster, A Fletcher, W L Gerald, H M&#248;ller, V E Reuter, P T Scardino, J Cuzick, J S de Bono
                    &amp; C S Cooper</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/xqIYYfhUFdY" height="1" width="1"/>]]></content:encoded>
<dc:title>Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer</dc:title>
<dc:creator>A H M Reid</dc:creator>
<dc:creator>G Attard</dc:creator>
<dc:creator>L Ambroisine</dc:creator>
<dc:creator>G Fisher</dc:creator>
<dc:creator>G Kovacs</dc:creator>
<dc:creator>D Brewer</dc:creator>
<dc:creator>J Clark</dc:creator>
<dc:creator>P Flohr</dc:creator>
<dc:creator>S Edwards</dc:creator>
<dc:creator>D M Berney</dc:creator>
<dc:creator>C S Foster</dc:creator>
<dc:creator>A Fletcher</dc:creator>
<dc:creator>W L Gerald</dc:creator>
<dc:creator>H Møller</dc:creator>
<dc:creator>V E Reuter</dc:creator>
<dc:creator>P T Scardino</dc:creator>
<dc:creator>J Cuzick</dc:creator>
<dc:creator>J S de Bono</dc:creator>
<dc:creator>C S Cooper</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605554</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, January 26, 2010</dc:source>
<dc:date>2010-01-26</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>January 26, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605554</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605554</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605554</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605556">
<title>Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/AAd8ZfDt9o8/sj.bjc.6605556</link>
<content:encoded><![CDATA[
            
<p>
<b>Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605556">doi:10.1038/sj.bjc.6605556</a>
</p>
<p>Authors: K Cuschieri, D H Brewster, A R W Williams, D Millan, G Murray, S Nicoll, J Imrie, A Hardie, C Graham
                    &amp; H A Cubie</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/AAd8ZfDt9o8" height="1" width="1"/>]]></content:encoded>
<dc:title>Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines</dc:title>
<dc:creator>K Cuschieri</dc:creator>
<dc:creator>D H Brewster</dc:creator>
<dc:creator>A R W Williams</dc:creator>
<dc:creator>D Millan</dc:creator>
<dc:creator>G Murray</dc:creator>
<dc:creator>S Nicoll</dc:creator>
<dc:creator>J Imrie</dc:creator>
<dc:creator>A Hardie</dc:creator>
<dc:creator>C Graham</dc:creator>
<dc:creator>H A Cubie</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605556</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605556</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605556</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605556</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605558">
<title>High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/cG_OEca4Aac/sj.bjc.6605558</link>
<content:encoded><![CDATA[
            
<p>
<b>High expression of Toll-like receptor 4&#47;myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605558">doi:10.1038/sj.bjc.6605558</a>
</p>
<p>Authors: E L Wang, Z R Qian, M Nakasono, T Tanahashi, K Yoshimoto, Y Bando, E Kudo, M Shimada
                    &amp; T Sano</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/cG_OEca4Aac" height="1" width="1"/>]]></content:encoded>
<dc:title>High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer</dc:title>
<dc:creator>E L Wang</dc:creator>
<dc:creator>Z R Qian</dc:creator>
<dc:creator>M Nakasono</dc:creator>
<dc:creator>T Tanahashi</dc:creator>
<dc:creator>K Yoshimoto</dc:creator>
<dc:creator>Y Bando</dc:creator>
<dc:creator>E Kudo</dc:creator>
<dc:creator>M Shimada</dc:creator>
<dc:creator>T Sano</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605558</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605558</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605558</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605558</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605559">
<title>Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/Gwfe7Vw22og/sj.bjc.6605559</link>
<content:encoded><![CDATA[
            
<p>
<b>Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic&#8211;pharmacodynamic analysis from the IELSG no. 20 trial</b>
</p>
<p>British Journal of Cancer advance online publication, February 2, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605559">doi:10.1038/sj.bjc.6605559</a>
</p>
<p>Authors: M Joerger, A D R Huitema, S Kr&#228;henb&#252;hl, J H M Schellens, T Cerny, M Reni, E Zucca, F Cavalli
                    &amp; A J M Ferreri</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/Gwfe7Vw22og" height="1" width="1"/>]]></content:encoded>
<dc:title>Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial</dc:title>
<dc:creator>M Joerger</dc:creator>
<dc:creator>A D R Huitema</dc:creator>
<dc:creator>S Krähenbühl</dc:creator>
<dc:creator>J H M Schellens</dc:creator>
<dc:creator>T Cerny</dc:creator>
<dc:creator>M Reni</dc:creator>
<dc:creator>E Zucca</dc:creator>
<dc:creator>F Cavalli</dc:creator>
<dc:creator>A J M Ferreri</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605559</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 2, 2010</dc:source>
<dc:date> 201-02-02</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 2, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605559</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605559</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605559</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605561">
<title>Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/0LtCF82Otzk/sj.bjc.6605561</link>
<content:encoded><![CDATA[
            
<p>
<b>Inhibitory effect of a TGF&#946; receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605561">doi:10.1038/sj.bjc.6605561</a>
</p>
<p>Authors: O Shinto, M Yashiro, H Kawajiri, K Shimizu, T Shimizu, A Miwa
                    &amp; K Hirakawa</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/0LtCF82Otzk" height="1" width="1"/>]]></content:encoded>
<dc:title>Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells</dc:title>
<dc:creator>O Shinto</dc:creator>
<dc:creator>M Yashiro</dc:creator>
<dc:creator>H Kawajiri</dc:creator>
<dc:creator>K Shimizu</dc:creator>
<dc:creator>T Shimizu</dc:creator>
<dc:creator>A Miwa</dc:creator>
<dc:creator>K Hirakawa</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605561</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605561</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605561</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605561</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605562">
<title>The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/j0mR3-KXG7k/sj.bjc.6605562</link>
<content:encoded><![CDATA[
            
<p>
<b>The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605562">doi:10.1038/sj.bjc.6605562</a>
</p>
<p>Authors: S T Russell, P M A Siren, M J Siren
                    &amp; M J Tisdale</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/j0mR3-KXG7k" height="1" width="1"/>]]></content:encoded>
<dc:title>The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate</dc:title>
<dc:creator>S T Russell</dc:creator>
<dc:creator>P M A Siren</dc:creator>
<dc:creator>M J Siren</dc:creator>
<dc:creator>M J Tisdale</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605562</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605562</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605562</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605562</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605563">
<title>Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/D3efuw7O_l4/sj.bjc.6605563</link>
<content:encoded><![CDATA[
            
<p>
<b>Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605563">doi:10.1038/sj.bjc.6605563</a>
</p>
<p>Authors: A N Jeppesen, H K Jensen, F Donskov, N Marcussen
                    &amp; H von der Maase</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/D3efuw7O_l4" height="1" width="1"/>]]></content:encoded>
<dc:title>Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma</dc:title>
<dc:creator>A N Jeppesen</dc:creator>
<dc:creator>H K Jensen</dc:creator>
<dc:creator>F Donskov</dc:creator>
<dc:creator>N Marcussen</dc:creator>
<dc:creator>H von der Maase</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605563</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605563</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605563</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605563</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605564">
<title>Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/j9H0A4hpZTk/sj.bjc.6605564</link>
<content:encoded><![CDATA[
            
<p>
<b>Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605564">doi:10.1038/sj.bjc.6605564</a>
</p>
<p>Authors: Y Hamaya, K Yoshida, T Takai, M Ikuma, A Hishida
                    &amp; S Kanaoka</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/j9H0A4hpZTk" height="1" width="1"/>]]></content:encoded>
<dc:title>Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer</dc:title>
<dc:creator>Y Hamaya</dc:creator>
<dc:creator>K Yoshida</dc:creator>
<dc:creator>T Takai</dc:creator>
<dc:creator>M Ikuma</dc:creator>
<dc:creator>A Hishida</dc:creator>
<dc:creator>S Kanaoka</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605564</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605564</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605564</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605564</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605567">
<title>Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/idAZWif42_Y/sj.bjc.6605567</link>
<content:encoded><![CDATA[
            
<p>
<b>Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605567">doi:10.1038/sj.bjc.6605567</a>
</p>
<p>Authors: A A M van der Veldt, M R Meijerink, A J M van den Eertwegh, J B A G Haanen
                    &amp; E Boven</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/idAZWif42_Y" height="1" width="1"/>]]></content:encoded>
<dc:title>Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib</dc:title>
<dc:creator>A A M van der Veldt</dc:creator>
<dc:creator>M R Meijerink</dc:creator>
<dc:creator>A J M van den Eertwegh</dc:creator>
<dc:creator>J B A G Haanen</dc:creator>
<dc:creator>E Boven</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605567</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605567</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605567</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605567</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/sj.bjc.6605572">
<title>MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers</title>
<link>http://feeds.nature.com/~r/bjc/rss/aop/~3/hPLx-cITFQg/sj.bjc.6605572</link>
<content:encoded><![CDATA[
            
<p>
<b>MEPE&#47;OF45 as a new target for sensitizing human tumour cells to DNA damage inducers</b>
</p>
<p>British Journal of Cancer advance online publication, February 9, 2010. <a href="http://dx.doi.org/10.1038/sj.bjc.6605572">doi:10.1038/sj.bjc.6605572</a>
</p>
<p>Authors: P Zhang, H Wang, P S N Rowe, B Hu
                    &amp; Y Wang</p>
<img src="http://feeds.feedburner.com/~r/bjc/rss/aop/~4/hPLx-cITFQg" height="1" width="1"/>]]></content:encoded>
<dc:title>MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers</dc:title>
<dc:creator>P Zhang</dc:creator>
<dc:creator>H Wang</dc:creator>
<dc:creator>P S N Rowe</dc:creator>
<dc:creator>B Hu</dc:creator>
<dc:creator>Y Wang</dc:creator>
<dc:identifier>doi:10.1038/sj.bjc.6605572</dc:identifier>
<dc:source>British Journal of Cancer advance online publication, February 9, 2010</dc:source>
<dc:date> 201-02-09</dc:date>
<prism:publicationName>British Journal of Cancer</prism:publicationName>
<prism:publicationDate>February 9, 2010</prism:publicationDate>
<prism:doi>10.1038/sj.bjc.6605572</prism:doi>
<prism:url>http://dx.doi.org/10.1038/sj.bjc.6605572</prism:url>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
<feedburner:origLink>http://dx.doi.org/10.1038/sj.bjc.6605572</feedburner:origLink></item>
</rdf:RDF>
